Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease
Petragen has raised $3.5M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Petragen is headquartered in Cambridge, United States.
Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease
Petragen is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Petragen — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/petragen. Accessed August 14, 2026.
VCBacked. (2022). Petragen — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/petragen
{{cite web |title=Petragen — Funding & Investors |url=https://www.vcbacked.co/company/petragen |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated